$QTNT on NASDAQ
December 12, 2022
Quotient Limited Announces Intent to Voluntary Delist from the Nasdaq Global Market
November 02, 2022
Quotient Limited Announces Reverse Stock Split Effective Today
October 31, 2022
Quotient Limited Announces Intent to Effect Reverse Stock Split
September 08, 2022
Quotient Limited Selected to Join the World Economic Forum New Champions Community
August 24, 2022
Quotient Limited Expands MosaiQ Innovator’s Circle to Empower Patient Care and Laboratory Efficiencies
August 09, 2022
Quotient Limited Provides First Quarter Fiscal 2023 Results and Business Update
August 02, 2022
Quotient Limited to Report First Quarter Fiscal 2023 Financial Results and Host Conference Call on August 9th
July 12, 2022
Quotient Limited and InfYnity Biomarkers Announce Partnership to Expand MosaiQ Infectious Disease Menu
July 01, 2022
Quotient Limited Announces Equity Awards
June 29, 2022
Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares and Pre-Funded Warrants
June 24, 2022
Quotient Limited Announces Pricing of Underwritten Offering
June 24, 2022
Quotient Limited Provides Fourth Quarter Fiscal 2022 Results and Business Update
June 23, 2022
Quotient Limited Announces Proposed Amendments to Senior Secured Notes
June 23, 2022
Quotient Limited Announces Proposed Underwritten Offering
June 21, 2022
Quotient Limited Reschedules Fourth Quarter and Full Year 2022 Financial Results Announcement to Friday, June 24th and Provides a Preview of Financials
June 17, 2022
Quotient Limited to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on June 22nd
June 08, 2022
Quotient Limited and Theradiag Announce Partnership to Advance Autoimmune Disease Diagnostics
May 17, 2022
Quotient Limited Announces Opening of Office in Dubai, United Arab Emirates
May 12, 2022
Quotient Limited to Host Key Opinion Leader Webinar on its MosaiQ™ Solution
April 26, 2022
Quotient Limited Announces Appointment of New Board Member
March 21, 2022
Quotient Limited Further Strengthens Scientific and Medical Synergies with the Expansion of the MosaiQ Innovator’s Circle
March 08, 2022
Quotient Limited Announces Receipt of CE Mark for the Extended Immunohematology Microarray
February 22, 2022
Quotient Limited to Participate in the Cowen 42nd Annual Health Care Conference
February 08, 2022
Quotient Limited Reports Third Quarter Fiscal 2022 Results and Provides Business Update
February 03, 2022
Quotient Limited to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 02, 2022
Quotient Limited Announces Equity Awards
February 01, 2022
Quotient Limited Provides MosaiQ Regulatory & Commercial Update
January 31, 2022
Quotient Limited to Report Third Quarter Fiscal Year 2022 Financial Results and Host Conference Call
January 26, 2022
Quotient Limited Launches Scientific Advisory Board and Research Programs
December 15, 2021
Quotient Limited Provides Update on MosaiQ Expanded Immunohematology Microarray CE Marking Progress
November 30, 2021
Quotient Limited Announces Appointment of Chief Manufacturing Operations Officer
November 19, 2021
Quotient Limited Announces Equity Awards
November 15, 2021
Quotient Limited Provides Second Quarter Fiscal 2022 Results
November 12, 2021
Quotient Limited to Participate in the Jefferies London Healthcare Conference
November 08, 2021
Quotient Limited Provides Business Update and Delays Releasing Second Quarter Fiscal 2022 Results
October 26, 2021
Quotient Limited to Report Second Quarter Fiscal Year 2022 Financial Results and Host Conference Call
October 14, 2021
Quotient Limited Announces receipt of Note Holders Consents to Indenture Amendments That Extend Maturity, Defer Principal Payments on 12% Senior Secured Notes
October 12, 2021
Quotient Limited Announces Appointment of Chief Financial Officer
October 05, 2021
Quotient Limited Announces Appointment of Chief Commercial Officer
October 04, 2021
Quotient Limited Announces Appointment of New Chief Scientific & Medical Officer
October 01, 2021
Quotient Limited Provides Update on CE Marking Progress of the MosaiQ™ Expanded Immunohematology Microarray
September 01, 2021
Quotient Limited Announces Christian Albrich as Chief People Officer
August 11, 2021
Quotient Limited Announces Departure of Chief Commercial Officer, Jeremy Stackawitz
August 05, 2021
Quotient Limited Provides First Quarter Fiscal 2022 Results and Business Update
August 02, 2021
Quotient Limited Announces Equity Awards
July 29, 2021
Quotient Limited to Report First Quarter Fiscal Year 2022 Financial Results and Host Conference Call
July 02, 2021
Quotient Limited Announces Departure of Chief Financial Officer, Peter Buhler
June 01, 2021
Quotient Limited Provides Fourth Quarter and Full Year Fiscal 2021 Results and provides Business Update
May 31, 2021
Quotient Limited to Participate in Upcoming Investor Conferences
May 25, 2021
Quotient Limited to Report Fiscal Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call
- No Recent Filings Found.
